Literature DB >> 20646340

Decreased interstitial FOXP3(+) lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12/CXCR4 axis.

Y Shimizu1, K Dobashi, K Endou, A Ono, N Yanagitani, M Utsugi, T Sano, T Ishizuka, K Shimizu, S Tanaka, M Mori.   

Abstract

Regulatory T cells (Treg) play a critical role in immune homeostasis and expansion of Treg is controlled by chemokine receptors. The chemokine CXCL12 and its G-protein-coupled receptor (CXCR4) are involved in the development of idiopathic pulmonary fibrosis (IPF), but the association of Treg with the CXCL12/CXCR4 axis has not been documented. The aim of this study is to determine the distribution and extent of CXCL12/CXCR4 expression in idiopathic type of pulmonary fibrosis, and the relation of Treg expansion in the interstitium of pulmonary fibrosis patients to CXCL12/CXCR4 expression. CXCL12 expression was examined by immunostaining and ELISA in tissue specimens from patients with usual interstitial pneumonia (UIP, n=15), patients with fibrotic non-specific interstitial pneumonia (f-NSIP, n=4), and controls (n=6). CXCR4 expression was examined by in situ hybridization and immunoblotting. Expression of CD45, CD3, CD20, transcription factor forkhead box P3 (FOXP3), and CD25 was assessed by immunostaining. Fibrosis was evaluated by determining the established fibrosis (EF) score. The CXCL12/CXCR4 axis was upregulated in UIP and f-NSIP, and CXCL12 derived from lung tissue attracted CXCR4(+) cells. CXCR4(+) cells showed a CD3(+) cell distribution pattern. The interstitial FOXP3(+)/CD3(+) and CD25(+)/CD3(+) cell ratios were lower in UIP than f-NSIP, but the CXCR4(+)/CD3(+) cell ratio was not different. The FOXP3(+)/CD3(+) cell ratio and EF score were inversely correlated. These findings suggest that the CXCL12/CXCR4 axis contributes to inflammation in UIP and f-NSIP by promoting the accumulation CXCR4(+) lymphocytes, and a decrease of Treg is correlated with the severity of fibrosis in UIP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646340     DOI: 10.1177/039463201002300207

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  13 in total

1.  Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.

Authors:  Daniel J Kass; Guoying Yu; Katrina S Loh; Asaf Savir; Alain Borczuk; Rehan Kahloon; Brenda Juan-Guardela; Giuseppe Deiuliis; John Tedrow; Jiin Choi; Thomas Richards; Naftali Kaminski; Steven M Greenberg
Journal:  Am J Pathol       Date:  2012-03-16       Impact factor: 4.307

2.  Activated human T lymphocytes inhibit TGFβ-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2.

Authors:  Shannon H Lacy; Amali P Epa; Stephen J Pollock; Collynn F Woeller; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-20       Impact factor: 5.464

3.  CD4(+)CD25(hi)Foxp3(+) Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Shirin Z Birjandi; Vyacheslav Palchevskiy; Ying Ying Xue; Stefanie Nunez; Rita Kern; S Sam Weigt; Joseph P Lynch; Talal A Chatila; John A Belperio
Journal:  Am J Pathol       Date:  2016-06-16       Impact factor: 4.307

Review 4.  The immune response to tumors as a tool toward immunotherapy.

Authors:  F Pandolfi; R Cianci; D Pagliari; F Casciano; C Bagalà; A Astone; R Landolfi; C Barone
Journal:  Clin Dev Immunol       Date:  2011-12-05

5.  Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis.

Authors:  Bethany B Moore; Chris Fry; Yueren Zhou; Susan Murray; MeiLan K Han; Fernando J Martinez; Kevin R Flaherty
Journal:  Front Med       Date:  2014-12-22       Impact factor: 4.592

6.  Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function.

Authors:  Ayodeji Adegunsoye; Cara L Hrusch; Catherine A Bonham; Mohammad R Jaffery; Kelly M Blaine; Meghan Sullivan; Matthew M Churpek; Mary E Strek; Imre Noth; Anne I Sperling
Journal:  Front Immunol       Date:  2016-11-23       Impact factor: 7.561

7.  Lymphoid Interstitial Pneumonia in Common Variable Immune Deficiency - Case Report With Disease Monitoring in Various Therapeutic Options: Pleiotropic Effects of Rituximab Regimens.

Authors:  Przemyslaw Zdziarski; Andrzej Gamian
Journal:  Front Pharmacol       Date:  2019-01-18       Impact factor: 5.810

8.  The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity.

Authors:  Fei Li; Xuefeng Xu; Jing Geng; Xuan Wan; Huaping Dai
Journal:  Exp Ther Med       Date:  2020-01-08       Impact factor: 2.447

9.  Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.

Authors:  Shanna L Ashley; Meng Xia; Susan Murray; David N O'Dwyer; Ethan Grant; Eric S White; Kevin R Flaherty; Fernando J Martinez; Bethany B Moore
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

10.  Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.

Authors:  Koichiro Kamio; Arata Azuma; Kuniko Matsuda; Jiro Usuki; Minoru Inomata; Akemi Morinaga; Takeru Kashiwada; Nobuhiko Nishijima; Shioto Itakura; Nariaki Kokuho; Kenichiro Atsumi; Hiroki Hayashi; Tomoyoshi Yamaguchi; Kazue Fujita; Yoshinobu Saito; Shinji Abe; Kaoru Kubota; Akihiko Gemma
Journal:  Respir Res       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.